Greenwich LifeSciences, Inc.·4

Jan 5, 6:06 AM ET

Patel Snehal 4

4 · Greenwich LifeSciences, Inc. · Filed Jan 5, 2026

Insider Transaction Report

Form 4
Period: 2025-12-31
Patel Snehal
DirectorCEO and CFO10% Owner
Transactions
  • Purchase

    Common Stock

    2025-12-31$21.36/sh+4,300$91,8485,599,402 total

Documents

1 file
  • 4
    ownership.xmlPrimary

    4